Real-world data fill knowledge gap to assess treatment options for infants with spinal muscular atrophy

Findings from a recent study in the Journal of Neuromuscular Diseases demonstrate the effectiveness of disease-modifying treatments (DMTs) in infants with spinal muscular atrophy (SMA). The study’s results add further support for gene therapy as a treatment modality that can deliver durable transformative effects for these vulnerable patients.